Abstract
We report a patient with RA who developed serological evidence for lupus disease in the presence of a crescentic immune complex glomerulonephritis (GN). This occurred after 4 years therapy with penicillamine and resolved on withdrawal of this drug and following treatment with cyclophosphamide.
MeSH terms
-
Arthritis, Rheumatoid / drug therapy
-
Cyclophosphamide / therapeutic use
-
Female
-
Glomerulosclerosis, Focal Segmental / chemically induced*
-
Glomerulosclerosis, Focal Segmental / complications
-
Humans
-
Lupus Erythematosus, Systemic / chemically induced*
-
Lupus Erythematosus, Systemic / complications
-
Middle Aged
-
Penicillamine / adverse effects*
-
Penicillamine / therapeutic use
Substances
-
Cyclophosphamide
-
Penicillamine